- Home
- TSHA vs ETD Comparison
TSHA vs ETD Comparison
Compare TSHA & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- ETD
- Stock Information
- Founded
- TSHA 2019
- ETD 1932
- Country
- TSHA United States
- ETD United States
- Employees
- TSHA N/A
- ETD N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- ETD Home Furnishings
- Sector
- TSHA Health Care
- ETD Consumer Discretionary
- Exchange
- TSHA Nasdaq
- ETD Nasdaq
- Market Cap
- TSHA 728.4M
- ETD 692.5M
- IPO Year
- TSHA 2020
- ETD 1993
- Fundamental
- Price
- TSHA $2.94
- ETD $29.85
- Analyst Decision
- TSHA Strong Buy
- ETD Hold
- Analyst Count
- TSHA 7
- ETD 2
- Target Price
- TSHA $8.71
- ETD $30.00
- AVG Volume (30 Days)
- TSHA 2.7M
- ETD 290.6K
- Earning Date
- TSHA 08-12-2025
- ETD 07-30-2025
- Dividend Yield
- TSHA N/A
- ETD 6.06%
- EPS Growth
- TSHA N/A
- ETD N/A
- EPS
- TSHA N/A
- ETD 2.01
- Revenue
- TSHA $8,098,000.00
- ETD $614,649,000.00
- Revenue This Year
- TSHA N/A
- ETD $0.62
- Revenue Next Year
- TSHA N/A
- ETD $4.06
- P/E Ratio
- TSHA N/A
- ETD $14.87
- Revenue Growth
- TSHA N/A
- ETD N/A
- 52 Week Low
- TSHA $1.05
- ETD $24.55
- 52 Week High
- TSHA $3.31
- ETD $33.77
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- ETD 54.42
- Support Level
- TSHA $2.69
- ETD $29.10
- Resistance Level
- TSHA $3.12
- ETD $30.67
- Average True Range (ATR)
- TSHA 0.17
- ETD 0.77
- MACD
- TSHA 0.02
- ETD 0.01
- Stochastic Oscillator
- TSHA 68.97
- ETD 58.63
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About ETD Ethan Allen Interiors Inc.
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.